SC Pharmaceuticals(SZ:002693) Mei Ri Jing Ji Xin Wen·2026-02-09 05:24Core Viewpoint - Company ST Shuangcheng (002693.SZ) has announced that its 2025 annual report is scheduled for disclosure on April 29, 2026, and it is committed to fulfilling its information disclosure obligations in accordance with relevant laws and regulations [1]. Group 1 - Company has received inquiries from investors regarding the feasibility and plans for early disclosure of the 2025 annual report [3]. - Investors expressed optimism about the company's forecasted profitability for the 2025 fiscal year, indicating potential for the company to remove its "ST" designation [3]. - Questions were raised about whether the company would expedite the process of removing the "ST" designation to stabilize market expectations and reduce investor anxiety [3].